We are live on ! Find out more
PGNX

Progenics Pharmaceuticals Inc
PGNX

Delisted

PGNX was delisted on the 19th of June, 2020.

Back to rankings

121 hedge funds and large institutions have $383M invested in Progenics Pharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 44 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more call options, than puts

Call options by funds: $1.02M | Put options by funds: $706K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less capital invested

Capital invested by funds: $385M → $383M (-$2.68M)

9% less funds holding

Funds holding: 133 → 121 (-12)

11% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 44

50% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 24

Holders
121
Holders Change
-12
Holders Change %
-9.02%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
39
Reduced
44
Closed
24
Calls
$1.02M
Puts
$706K
Net Calls
+$310K
Net Calls Change
+$56K

Top Buyers

Rank Fund Capital Flow
1
RHJA
Rice Hall James & Associates
California
+$2.69M
2
TC
TFS Capital
Pennsylvania
+$2.19M
3
NI
Numeric Investors
Massachusetts
+$1.9M
4
AI
Analytic Investors
California
+$859K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$774K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$14.1M
2
RA
Royce & Associates
New York
-$4.57M
3
BIM
Bogle Investment Management
Massachusetts
-$4.52M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.97M
5
EI
EAM Investors
California
-$2.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$2.07M +$25.1K +3,831 +1%
BA
27
BKS Advisors
Michigan
$1.78M – – –
TI
28
Turner Investments
Pennsylvania
$1.55M – – –
BIM
29
BlackRock Investment Management
Delaware
$1.5M +$970 +148 +0.1%
TCIM
30
TIAA CREF Investment Management
New York
$1.39M -$154K -23,449 -9%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$1.35M – – –
AI
32
Analytic Investors
California
$1.26M +$859K +130,995 +176%
PAM
33
Panagora Asset Management
Massachusetts
$1.24M +$83.3K +12,712 +7%
Deutsche Bank
34
Deutsche Bank
Germany
$985K -$2.1M -320,650 -67%
SGAM
35
Smith Group Asset Management
Texas
$935K -$23.5K -3,590 -2%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$931K +$35.3K +5,382 +4%
Goldman Sachs
37
Goldman Sachs
New York
$891K -$246K -37,460 -20%
Fisher Asset Management
38
Fisher Asset Management
Washington
$859K +$373K +56,941 +68%
SAMC
39
Shinko Asset Management Company
Japan
$859K +$373K +56,941 +68%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$791K +$14.8K +2,257 +2%
CCM
41
Cadence Capital Management
Massachusetts
$785K -$139K -21,136 -14%
UBS Group
42
UBS Group
Switzerland
$783K +$734K +111,971 +709%
SO
43
STRS Ohio
Ohio
$660K +$50.8K +7,753 +8%
AIG
44
American International Group
New York
$647K +$55.4K +8,448 +9%
VEA
45
Virtus ETF Advisers
New York
$636K +$681K +103,807 New
Thrivent Financial for Lutherans
46
Thrivent Financial for Lutherans
Minnesota
$633K +$677K +103,280 New
Charles Schwab
47
Charles Schwab
California
$629K -$22.3K -3,400 -3%
AllianceBernstein
48
AllianceBernstein
Tennessee
$628K +$4.79K +730 +0.7%
TA
49
Teachers Advisors
New York
$624K – – –
Swiss National Bank
50
Swiss National Bank
Switzerland
$579K – – –
1
2
3 4 5

PGNX Hedge Fund Activity: Q4 2015 in Review

121 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Progenics Pharmaceuticals Inc (PGNX) for Q4 2015, worth a combined $383M — down 0.7% from $385M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of PGNX and 12 opened new positions — a net loss of 12 holders — while 44 trimmed existing stakes and 39 added.

The largest buyer was Rice Hall James & Associates, adding an estimated $2.69M. The largest seller was State Street, cutting an estimated $14.1M.

  • 121 institutional investors held Progenics Pharmaceuticals Inc (PGNX) as of Q4 2015, down from 133 in Q3 2015.
  • Funds reported $383M of Progenics Pharmaceuticals Inc stock for Q4 2015, down 0.7% quarter-over-quarter.
  • 12 funds opened new Progenics Pharmaceuticals Inc positions in Q4 2015 and 24 closed out, a net change of -12 holders.
  • The largest Progenics Pharmaceuticals Inc buyer in Q4 2015 was Rice Hall James & Associates, an estimated $2.69M added.
  • The largest Progenics Pharmaceuticals Inc seller in Q4 2015 was State Street, an estimated $14.1M sold.

Based on aggregated 13F filings for Q4 2015.